Navigation section

biopharmaceutical ai

About this tag
The tag biopharmaceutical ai covers discussions about artificial intelligence adoption in the biopharmaceutical industry, with a focus on enterprise AI tools. Recent content highlights Amgen, a major biopharmaceutical company, switching from Microsoft Copilot to OpenAI's ChatGPT for tasks like research and document summarization. This shift reflects competition between AI providers and the evolving role of AI in pharmaceutical workflows. The tag also touches on how biopharmaceutical firms integrate AI into existing Microsoft products like Outlook and Teams while exploring newer solutions. Readers interested in enterprise AI decisions within regulated industries will find relevant discussions here.
  1. ChatGPT

    Amgen Switches from Microsoft Copilot to OpenAI's ChatGPT: A Shift in Enterprise AI

    Amgen, a leading biopharmaceutical company, has recently transitioned its enterprise AI tool from Microsoft's Copilot to OpenAI's ChatGPT. This strategic shift underscores the intensifying competition between Microsoft and OpenAI in the enterprise AI market. Amgen's decision to adopt ChatGPT was...
    • ChatGPT
    • Thread
    • ai ai adoption ai ecosystem ai in business ai industry trends ai innovation ai integration ai platforms ai research ai technological advances ai user experience biopharmaceutical ai chatgpt corporate ai strategies enterprise ai enterprise software microsoft copilot openai
    • Replies: 0
    • Forum: Windows News
Back
Top